Results from AD mouse models suggest that ApoA1 may be regulated by distinct mechanisms on either side of the blood–brain barrier (BBB) and that ApoA1 may serve to integrate peripheral and CNS lipid metabolism [28]. The gene discussed is APOA1; the disease is Alzheimer disease.